Literature DB >> 30711802

Generation of induced pluripotent stem cells (iPSCs) from patient with Cri du Chat Syndrome.

Giovanna Piovani1, Gaetana Lanzi2, Rosalba Monica Ferraro2, Stefania Masneri2, Chiara Barisani2, Giulia Savio3, Silvia Clara Giliani2.   

Abstract

The Cri du Chat Syndrome (CdCS) is a genetic disease resulting from variable size deletion occurring on the short arm of chromosome 5. The main clinical features are a high-pitched monochromatic cry, microcephaly, severe psychomotor and mental retardation with characteristics of autism spectrum disorders such as hand flapping, obsessive attachments to objects, twirling objects, repetitive movements, and rocking. We reprogrammed to pluripotency peripheral blood mononuclear cells derived from a patient carrying large deletion on the short arm of chromosome 5, using a commercially available non-integrating expression system. The iPSCs expressed pluripotency markers and differentiated in the three embryonic germ layers.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30711802     DOI: 10.1016/j.scr.2019.101393

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  2 in total

Review 1.  A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15.

Authors:  Alessia Casamassa; Daniela Ferrari; Maurizio Gelati; Massimo Carella; Angelo Luigi Vescovi; Jessica Rosati
Journal:  Int J Mol Sci       Date:  2020-03-09       Impact factor: 5.923

Review 2.  Copy number variants (CNVs): a powerful tool for iPSC-based modelling of ASD.

Authors:  Danijela Drakulic; Srdjan Djurovic; Yasir Ahmed Syed; Sebastiano Trattaro; Nicolò Caporale; Anna Falk; Rivka Ofir; Vivi M Heine; Samuel J R A Chawner; Antonio Rodriguez-Moreno; Marianne B M van den Bree; Giuseppe Testa; Spyros Petrakis; Adrian J Harwood
Journal:  Mol Autism       Date:  2020-06-01       Impact factor: 7.509

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.